Enzymatic release of nitric oxide from L-alanosine,an antineoplastic antibiotic

L-Alanosine is an antineoplastic drug which is the 3-isonitramino analog of $\text{L}$-aspartic acid. The drug is known to be metabolized to the corresponding 2-oxo acid. Unlike the parent amino acid, the 2-oxo acid is unstable under mild conditions. When the 2-oxo acid is generated $\text{in}\text{vitro}$ by the aerobic action of $\text{L}$-amino acid oxidase on $\text{L}$-alanosine, the reaction mixture contains products capable of diazotizing sulfanilamide and of reducing ferricytochrome $\text{c}$ to ferrocytochrome $\text{c}$. It is thus likely that, as expected from model reactions, the unstable 2-oxo acid derived from $\text{L}$-alanosine decomposes into nitric oxide and other reactive free-radical species. Enzymatically promoted production of highly cytotoxic nitric oxide may pertain to the biological activity of the antibiotic. The reaction should prove extrapolable to the design of other enzyme-activated cytotoxic agents.